DNA Synthesis Market Size to Surpass USD 20.87 Bn by 2032
January 10, 2024 11:00 ET
|
Precedence Research
Ottawa, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The global DNA synthesis market size is currently valued at more than USD 4.96 billion and is projected to reach USD 14.50 billion by 2030, expanding at a...
Global Enzymatic DNA Synthesis Market Analysis, Trends and Forecasts to 2028 - Opportunities in CRISPR-Cas9 Integration and Cell-Free Synthetic Biology
December 12, 2023 05:23 ET
|
Research and Markets
Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "Global Enzymatic DNA Synthesis Market: Analysis By Product Type (DNA Library Synthesis and Custom DNA Synthesis), By Technology (PCR, CRISPR, SOLA and...
Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
November 03, 2023 12:00 ET
|
Telesis Bio
SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp®...
Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS
September 28, 2023 15:48 ET
|
Telesis Bio
SAN DIEGO, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp®...
Gene Synthesis Market Size & Share to Surpass $6.58 Billion by 2028 | Vantage Market Research
March 27, 2023 07:02 ET
|
Vantage Market Research
WASHINGTON, March 27, 2023 (GLOBE NEWSWIRE) -- Global Gene Synthesis Market is valued at USD 2.16 Billion in 2021 and is projected to reach USD 6.58 Billion by 2028 at a CAGR (Compound Annual Growth...
Enormous Investments in Biotechnology to Propel the Gene Synthesis Market Grow at 19.2% from 2023 to 2033: Future Market Insights, Inc.
January 23, 2023 08:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Jan. 23, 2023 (GLOBE NEWSWIRE) -- As per FMI, the gene synthesis market is expected to reach US$ 779.4 million in 2023. Furthermore, the market is projected to record a CAGR of 19.2%...
Telesis Bio Inc. Reports Third Quarter 2022 Financial Results
November 08, 2022 16:10 ET
|
Telesis Bio
-- Record revenue of $6.7M in 3QFY22; Increase of 140% over $2.8M 3QFY 2021 -- BioXp® Kit Revenue increased to $884k, or 69% in 3QFY22 over 3QFY2021 -- Increases revenue guidance to $23 million to...
Codex DNA Announces Plan to Change Corporate Name to Telesis Bio
October 12, 2022 09:00 ET
|
Codex DNA, Inc.
SAN DIEGO, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, today announced a plan to change its Company name to...
Codex DNA weitet Anwendung der firmeneigenen Fehlerkorrekturtechnologie aus
October 04, 2022 09:00 ET
|
Codex DNA, Inc.
SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), ein Pionier im Bereich automatisierter Tischsysteme für die synthetische Biologie, gab heute die Markteinführung der...
Codex DNA Expands Application of Proprietary Error Correction Technology
October 04, 2022 09:00 ET
|
Codex DNA, Inc.
SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced commercial release of BioXp® Error-corrected...